[Eosinopenia in 2018]

H Gil; B Bouldoires; B Bailly; N Meaux Ruault; S Humbert; N Magy-Bertrand

doi:10.1016/j.revmed.2018.11.008

[Eosinopenia in 2018]

Rev Med Interne. 2019 Mar;40(3):173-177. doi: 10.1016/j.revmed.2018.11.008. Epub 2018 Nov 27.

[Article in French]

Authors

H Gil¹, B Bouldoires², B Bailly², N Meaux Ruault², S Humbert², N Magy-Bertrand²

Affiliations

¹ Service de médecine interne, CHU Jean-Minjoz, 25000 Besançon, France. Electronic address: [email protected].
² Service de médecine interne, CHU Jean-Minjoz, 25000 Besançon, France.

PMID: 30501929
DOI: 10.1016/j.revmed.2018.11.008

Abstract

Since 1893, eosinopenia is a biological test to help a diagnosis of bacterial infection. Several publications have confirmed this hypothesis, particularly in the intensive care, pneumology and pediatric units. The value of this marker has been identified in vascular cerebral diseases and coronary bypass. Its contribution seems as relevant as procalcitonin, without extra cost. The diagnostic performance of this test was reinforced by a composite score (CIBLE score) that may improve its value in daily routine. Finally, monitoring eosinopenia appears to be a reliable mortality marker.

Keywords: Bacterial infection; Eosinopenia; Infections bactériennes; Polynuclear eosinophil; Polynucléaires éosinophiles; Éosinopénie.

Publication types

Review

MeSH terms

Agranulocytosis / diagnosis*
Agranulocytosis / etiology
Agranulocytosis / pathology
Bacterial Infections / blood
Bacterial Infections / complications
Bacterial Infections / diagnosis
Eosinophils / pathology*
Hematology / methods
Hematology / trends*
Humans
Leukocyte Count
Prognosis